|
SLC35B1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.43690000001351E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.20829999999906E-05 |
| Normal-vs-Stage2 |
7.340000E-01 |
| Normal-vs-Stage3 |
8.4449000015141E-09 |
| Normal-vs-Stage4 |
6.28189944507085E-10 |
| Stage1-vs-Stage2 |
9.431000E-04 |
| Stage1-vs-Stage3 |
8.883200E-03 |
| Stage1-vs-Stage4 |
1.431750E-04 |
| Stage2-vs-Stage3 |
9.09439999974282E-07 |
| Stage2-vs-Stage4 |
2.68630000022085E-07 |
| Stage3-vs-Stage4 |
1.821640E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.85519999865258E-08 |
| Normal-vs-AfricanAmerican |
2.037600E-03 |
| Normal-vs-Asian |
2.86890000000817E-06 |
| Caucasian-vs-AfricanAmerican |
8.634400E-01 |
| Caucasian-vs-Asian |
9.578600E-01 |
| AfricanAmerican-vs-Asian |
8.639000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.99859999958785E-07 |
| Normal-vs-Female |
2.30619999999071E-05 |
| Male-vs-Female |
4.287800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.74019999999287E-05 |
| Normal-vs-Age(41-60Yrs) |
2.30320000005335E-06 |
| Normal-vs-Age(61-80Yrs) |
3.991100E-04 |
| Normal-vs-Age(81-100Yrs) |
1.136760E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.783000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.317800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.477000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.128200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.821400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.175200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.19049997532517E-09 |
| Classical-VS-Follicular |
3.13330472678786E-11 |
| Classical-VS-Other |
1.143570E-01 |
| Classical-VS-Normal |
1.57539981060495E-10 |
| Tall-VS-Follicular |
1.62447832963153E-12 |
| Tall-VS-Other |
5.204200E-02 |
| Tall-VS-Normal |
1.62492241884138E-12 |
| Follicular-VS-Other |
5.95910000011912E-07 |
| Follicular-VS-Normal |
3.936800E-01 |
| Other-VS-Normal |
4.5671999999719E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.484450E-02 |
| Normal-vs-N1 |
3.43119999079988E-09 |
| N0-vs-N1 |
1.89138999999727E-05 |
|
|
